Milo Biotechnology Receives $250,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ed18c7f7-c0e6-4596-9231-410c6237f797&Preview=1 -
Date
2/17/2012 -
Company Name
Milo Biotechnology -
Mailing Address
Undisclosed Cleveland, OH 44101 -
Company Description
Milo Biotechnology is a Cleveland-based company dedicated to improving the lives of patients with neuromuscular diseases. Milo’s early clinical stage follistatin program, exclusively licensed from Nationwide Children’s Hospital, is designed to increase muscle size and strength. -
Website
Undisclosed
-
Transaction Type
Venture Equity -
Transaction Amount
$250,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Jumpstart
